Sorted By:

Relevance


Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Learn more about how patients and payers are impacted.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-september-25-2015

Week in Review: The latest from PhRMA

PhRMA  |  Blog Post

Find out more about how the 340B program may not be reaching those in need.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-april-29-2016

Study highlights negative impact of Canada's promise doctrine on R and D investment

PhRMA  |  Blog Post

A newly published study from Charles River Associates (CRA) has found that Canada’s approach to intellectual property (IP), innovation and patient care is being jeopardized because of its adoption of a unique legal theory – the promise doctrine.
http://catalyst.phrma.org/study-highlights-negative-impact-of-canadas-promise-doctrine-on-rd-investment

ICYMI: Innovative payment models helping provide patient access to new medicines

PhRMA  |  Blog Post

As we continue to make remarkable strides to treat our most costly and challenging diseases, there is a renewed focus on ensuring patients have affordable access to the most innovative medicines.
http://catalyst.phrma.org/icymi-innovative-payment-models-helping-provide-patient-access-to-new-medicines

Contact PhRMA

PhRMA  |  From PhRMA

General Contact Information Pharmaceutical Research and Manufacturers of AmericaPhRMA Headquarters950 F Street, NW Suite 300, Washington, DC 20004Phone: (202) 835-3400www.PhRMA.orgwww.Facebook.com/PhRMAwww.Twitter.com/PhRMA www.YouTube.com/user/PhRMAPress www.LinkedIn.com/company/phrma Media If you are a member of the media, contact the Communications & Public Affairs department.
https://www.phrma.org/contact-us

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Learn more about the history of contract pharmacy arrangements and why a policy change in 2010 led to a dramatic increase in the volume of contract pharmacies.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-october-2-2015

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

PhRMA  |  Blog Post

As PhRMA reported in June, there are currently more than 240 immuno-oncology medicines and vaccines in development to help treat cancer.
http://catalyst.phrma.org/phrma-member-companies-and-nih-create-public-private-partnership-for-immuno-oncology

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Get updates on this subject and/or other relevant issues here. 
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-april-3-2015

Medicare Monday: How to switch plans during open enrollment

PhRMA  |  Blog Post

One recent study noted beneficiaries can save an average of $400 to $600 per year by switching.
http://catalyst.phrma.org/medicare-monday-how-to-switch-plans-during-open-enrollment

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Learn the facts and see why the number is actually much higher and is expected to rise.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-june-5-2015

PhRMA Statement on President’s FY2017 Budget

PhRMA  |  Blog Post

Continued focus on thoughtfully reforming the 340B program to help vulnerable or underserved patients is needed.
http://catalyst.phrma.org/phrma-statement-on-presidents-fy2017-budget

Biopharmaceutical Industry Speakers List

PhRMA  |  From PhRMA

For more information, email newsroom@phrma.org or call 202-835-3460.
https://www.phrma.org/press-room/biopharmaceutical-industry-speakers-list1

Manager – Public Affairs

PhRMA  |  PhRMA Career

www.Innovation.orgwww.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA What we offerIn addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members.
https://www.phrma.org

Biopharmaceutical companies reaffirm commitment to patients in updated Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results

PhRMA  |  Blog Post


http://catalyst.phrma.org/biopharmaceutical-companies-reaffirm-commitment-to-patients-in-updated-principles-on-conduct-of-clinical-trials-and-communication-of-clinical-trial-results

International

PhRMA  |  From PhRMA

In their statement, PhRMA noted that: “The Special 301 process continues to be effective in gaining high-level attention from our trading partners—attention that is needed to redress intellectual property violations and market access concerns.”
https://www.phrma.org/international

ICYMI: Community Oncologists Speak Out Against Hospital Cancer Doctors’ Drug Price Control Proposals

PhRMA  |  Blog Post

According to Community Oncology Alliance Executive Director Okon, “Most of the doctors who endorsed the recommendations in the journal are employed by large teaching institutions, many of which receive 340B drug discounts, and nearly 30 percent of the signatories are employed by a small group of hospitals where cancer care is high even compared to teaching hospitals.
http://catalyst.phrma.org/icymi-community-oncologists-speak-out-against-hospital-cancer-doctors-drug-price-control-proposals

Director – Federal Advocacy

PhRMA  |  PhRMA Career

www.Innovation.orgwww.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA What we offer In addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members. 
https://www.phrma.org

The R&D Challenges in tackling Ebola

PhRMA  |  Video

Ripley Ballou, like many public health specialists, believes that vaccines will have an important role to play in stopping the catastrophic outbreak in West Africa, which has so far caused at least 6553 cases and more than 3000 deaths in Guinea, Sierra Leone, and Liberia.
https://www.phrma.org/video/the-randd-challenges-in-tackling-ebola

Fact Check Friday: the truth about biopharmaceutical patents

PhRMA  |  Blog Post


http://catalyst.phrma.org/fact-check-friday-the-truth-about-biopharmaceutical-patents

Introduction

Chartpack  |  From Our Network

This chart pack features key facts about prescription medicines in four major government programs—Medicare, Medicaid, the US Department of Veterans Affairs (VA) and the 340B program.
http://chartpack.phrma.org/programs-chartpack/introduction/introduction

PPA connects nearly 10 million people; Celebrates 11th anniversary and launches mobile app

PhRMA  |  Blog Post


http://catalyst.phrma.org/ppa-celebrates-11th-anniversary-and-launches-mobile-app

Mental health in the New Era of Medicine

PhRMA  |  Blog Post

To dig deeper on mental health, PhRMA is continuing our national dialogue series with “.splashthat.com/?
http://catalyst.phrma.org/mental-health-in-the-new-era-of-medicine

ICYMI: New era of medicine initiative kicks off in Boston

PhRMA  |  Blog Post

Gilmore O'Neill of Biogen speaks on what it takes to fund the future of science and innovation.
http://catalyst.phrma.org/icymi-new-era-of-medicine-initiative-kicks-off-in-boston

Medicare Monday: Strengthening access to vaccines for seniors

PhRMA  |  Blog Post

Or look at cancer – there are currently 96 cancer vaccines in development harnessing the body’s own immune system to protect against the disease.  
http://catalyst.phrma.org/medicare-monday-strengthening-access-to-vaccines-for-seniors

Going boldly together: New advancements and new anniversaries

PhRMA  |  Blog Post

I had the great pleasure of meeting Salim and Roxanne in person during our GOBOLDLY Together shoots earlier this year, and it brought back some memories for me.
http://catalyst.phrma.org/going-boldly-together-new-advancements-and-new-anniversaries

You have reviewed the first 150 results out of 429. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next